More News
31 July 2019
Alizé Pharma 3 raises €67 million ($75 million) in Series A from a strong international syndicate26 July 2019
Alexion Receives Positive CHMP Opinion for SOLIRIS® (eculizumab) for the Treatment of NMOSD23 July 2019
DURECT and Gilead Enter into License Agreement for Long-Acting Injectable HIV Investigational Product21 July 2019
Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis18 July 2019
Inflection Biosciences and AUM Biosciences Announce Global License Agreement for PIM/PI3K/mTOR Inhibitors16 July 2019
Sosei Heptares Enters Into Multi-target Research Collaboration and License Agreement With Genentech11 July 2019
Report Package: Bispecific Antibodies11 July 2019
vasopharm Closes € 9.5 million Financing RoundNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports